These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34737714)

  • 1. Investigating Care Dependency and Its Relation to Outcome (ICARE): Results From a Naturalistic Study of an Intensive Day Treatment Program for Depression.
    Glanert S; Sürig S; Grave U; Fassbinder E; Schwab S; Borgwardt S; Klein JP
    Front Psychiatry; 2021; 12():644972. PubMed ID: 34737714
    [No Abstract]   [Full Text] [Related]  

  • 2. Change in Interpersonal and Metacognitive Skills During Treatment With Cognitive Behavioral Analysis System of Psychotherapy and Metacognitive Therapy: Results From an Observational Study.
    Sürig S; Ohm K; Grave U; Glanert S; Herzog P; Fassbinder E; Borgwardt S; Klein JP
    Front Psychiatry; 2021; 12():619674. PubMed ID: 34483977
    [No Abstract]   [Full Text] [Related]  

  • 3. Does childhood emotional abuse moderate the effect of cognitive behavioral analysis system of psychotherapy versus meta-cognitive therapy in depression? A propensity score analysis on an observational study.
    Klein JP; Dale R; Glanert S; Grave U; Surig S; Zurowski B; Borgwardt S; Schweiger U; Fassbinder E; Probst T
    J Affect Disord; 2022 Mar; 300():71-75. PubMed ID: 34952120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the feasibility and effectiveness of a modular treatment program for children and adolescents with depression and interpersonal problems: study protocol of a quasi-experimental pilot feasibility trial (CBASP@YoungAge).
    Dippel N; In-Albon T; Schneider S; Christiansen H; Brakemeier EL
    Pilot Feasibility Stud; 2022 Jul; 8(1):145. PubMed ID: 35821072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
    Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
    Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group Cognitive Behavioral Analysis System of Psychotherapy (CBASP): A Pilot Study for Bipolar Depression.
    Sayegh L; Touré EH; Farquhar E; Beaulieu S; Renaud S; Rej S; Perreault M
    Front Psychiatry; 2020; 11():565681. PubMed ID: 33173513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Psychometric Evaluation of the German Version of the Quick Inventory of Depressive Symptomatology (QIDS-SR16) in Outpatients with Depression.
    Roniger A; Späth C; Schweiger U; Klein JP
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):e17-22. PubMed ID: 26714254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.
    Sabaß L; Padberg F; Normann C; Engel V; Konrad C; Helmle K; Jobst A; Worlitz A; Brakemeier EL
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):783-796. PubMed ID: 28956140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients": Correction to Michalak et al. (2015).
    J Consult Clin Psychol; 2016 Jun; 84(6):510. PubMed ID: 27195443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16): a psychometric analysis in a clinical sample.
    Trujols J; de Diego-Adeliño J; Feliu-Soler A; Iraurgi I; Puigdemont D; Alvarez E; Pérez V; Portella MJ
    J Affect Disord; 2014 Dec; 169():189-96. PubMed ID: 25212994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study.
    Winter L; Schweiger U; Kahl KG
    BMC Psychiatry; 2020 Nov; 20(1):566. PubMed ID: 33243217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial.
    Callesen P; Reeves D; Heal C; Wells A
    Sci Rep; 2020 May; 10(1):7878. PubMed ID: 32398710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients.
    Michalak J; Schultze M; Heidenreich T; Schramm E
    J Consult Clin Psychol; 2015 Oct; 83(5):951-63. PubMed ID: 26371617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Effects of a Multimodal Inpatient CBASP Program: Rate of Occurrence and Their Impact on Treatment Outcome in Chronic and Treatment-Resistant Depression.
    Herzog P; Häusler S; Normann C; Brakemeier EL
    Front Psychiatry; 2021; 12():575837. PubMed ID: 34434122
    [No Abstract]   [Full Text] [Related]  

  • 15. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
    McIntyre RS; Lipsitz O; Lui LMW; Rodrigues NB; Gill H; Nasri F; Ling R; Teopiz KM; Ho RC; Subramaniapillai M; Kratiuk K; Mansur RB; Jones BDM; Lee Y; Rosenblat JD
    J Affect Disord; 2021 Nov; 294():592-596. PubMed ID: 34332360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of the cognitive behavioral analysis system of psychotherapy for chronic depression: a randomized controlled trial.
    Wiersma JE; Van Schaik DJ; Hoogendorn AW; Dekker JJ; Van HL; Schoevers RA; Blom MB; Maas K; Smit JH; McCullough JP; Beekman AT; Van Oppen P
    Psychother Psychosom; 2014; 83(5):263-9. PubMed ID: 25116461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression.
    Schramm E; Kriston L; Elsaesser M; Fangmeier T; Meister R; Bausch P; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Löwe B; Walter H; Wolf M; Domschke K; Berger M; Hautzinger M; Härter M
    Psychother Psychosom; 2019; 88(3):154-164. PubMed ID: 31121581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
    Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-Behavioral Analysis System of Psychotherapy, Drug, or Their Combination for Persistent Depressive Disorder: Personalizing the Treatment Choice Using Individual Participant Data Network Metaregression.
    Furukawa TA; Efthimiou O; Weitz ES; Cipriani A; Keller MB; Kocsis JH; Klein DN; Michalak J; Salanti G; Cuijpers P; Schramm E
    Psychother Psychosom; 2018; 87(3):140-153. PubMed ID: 29847831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.
    Jobst A; Sabaß L; Hall D; Brücklmeier B; Buchheim A; Hall J; Sarubin N; Zill P; Falkai P; Brakemeier EL; Padberg F
    J Affect Disord; 2018 Feb; 227():206-213. PubMed ID: 29100154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.